HIVE Digital Technologies (HIVE) had the highest return in September 2017 by a US stock, returning 1,225%.
| ASSET | MONTH | % RETURN |
|---|---|---|
HIVE Digital Technologies (HIVE) | September 2017 | 1,225% |
IZEA (IZEA) | September 2017 | 298.88% |
Anixa Biosciences (ANIX) | September 2017 | 286.76% |
Empire Petroleum (EP) | September 2017 | 280% |
Quantum Computing (QUBT) | September 2017 | 200% |
Veritone (VERI) | September 2017 | 192.66% |
Capricor Therapeutics (CAPR) | September 2017 | 188.57% |
Madrigal Pharmaceuticals (MDGL) | September 2017 | 165.02% |
Insmed (INSM) | September 2017 | 151.69% |
TDH (PETZ) | September 2017 | 148.89% |
Voyager Therapeutics (VYGR) | September 2017 | 112.27% |
Kura Oncology (KURA) | September 2017 | 106.21% |
TSS, Inc Common Stock (TSSI) | September 2017 | 100% |
Nutex Health (NUTX) | September 2017 | 95.27% |
Applied Digital (APLD) | September 2017 | 85.71% |
Viking Therapeutics (VKTX) | September 2017 | 81.9% |
InMed Pharmaceuticals (INM) | September 2017 | 79.37% |
Savara (SVRA) | September 2017 | 78.1% |
Versus Systems Inc. (VS) | September 2017 | 75.74% |
Akari Therapeutics (AKTX) | September 2017 | 71.99% |
Rocket Pharmaceuticals (RCKT) | September 2017 | 71.15% |
Aldeyra (ALDX) | September 2017 | 69.41% |
Roku (ROKU) | September 2017 | 68.19% |
Enphase Energy (ENPH) | September 2017 | 67.03% |
aTyr Pharma (ATYR) | September 2017 | 66.94% |